VEGFA and diabetic macular edema: <h4>Aim</h4>To quantitatively analyze change in the extent of hard exudates (HEs) following anti-VEGF therapy for diabetic macular edema (DME) and its relationships with visual outcomes.<h4>Methods</h4>This post-hoc analysis of DRCR Protocol T included 260 eyes of 260 patients.